Results 31 to 40 of about 12,135 (165)

Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients

open access: yesJournal of Infection in Developing Countries, 2013
Introduction: The distribution of both malaria and schistosomiasis exhibits a large geographical overlap in tropical environments, particularly in sub-Saharan Africa. This part of the world currently harbours more than 85% of the estimated global burden
Solomon M Abay   +3 more
doaj   +1 more source

MOESM4 of Absence of in vivo selection for K13 mutations after artemetherâ lumefantrine treatment in Uganda

open access: yes, 2017
Additional file 4. Recrudescence versus re-infection test results of recurrent malaria infections.
Balikagala, Betty   +17 more
openaire   +1 more source

Adherence to a Six-Dose Regimen of Artemether-Lumefantrine for Treatment of Uncomplicated Plasmodium Falciparum Malaria in Uganda. [PDF]

open access: yes, 2004
Measuring baseline levels of adherence and identifying risk factors for non-adherence are important steps before the introduction of new antimalarials. In Mbarara in southwestern Uganda, we assessed adherence to artemether-lumefantrine (Coartem) in its ...
Bajunirwe, F   +19 more
core   +1 more source

Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule

open access: yesJournal of Pharmacy and Bioallied Sciences, 2012
Artemether and Lumefantrine capsules are indicated for the treatment of P. falciparum malaria cases resistant to both chloroquine and sulphadoxine, pyrimethamine combination. Both artemether and lumefantrine act as blood schizontocides.
A Patel   +5 more
doaj   +1 more source

Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania

open access: yesMalaria Journal, 2020
Background Extended artemisinin-based combination therapy (ACT) for treatment of uncomplicated Plasmodium falciparum malaria with already existing drug regimens, such as artemether-lumefantrine, might be effective in tackling the emerging ACT resistance.
Lwidiko E. Mhamilawa   +4 more
doaj   +1 more source

MOESM1 of A case of blackwater fever with persistent Plasmodium falciparum parasitaemia detected by PCR after artemetherâ lumefantrine treatment

open access: yes, 2018
Additional file 1. Tests on molecular markers associated with anti-malarial drug resistance.
Huggan, Paul   +4 more
openaire   +1 more source

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens. [PDF]

open access: yes, 2015
BACKGROUND: The burden of malaria remains high for children in parts of Africa despite the use of insecticide-treated bed nets (ITNs). Chemoprevention has the potential of reducing the malaria burden; however, limited data exist on the efficacy and ...
Tamara Clark   +17 more
core   +1 more source

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults

open access: yes, 2022
Despite repeated malaria infection, individuals living in malaria endemic areas remain vulnerable to re-infection. The Janus kinase (JAK1/2) inhibitor ruxolitinib could potentially disrupt the parasite-induced dysfunctional immune response when ...
El Gaaloul, Myriam   +53 more
core   +1 more source

A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya

open access: yesMalaria Journal, 2008
Background Artemether/lumefantrine (AL) has been adopted as the treatment of choice for uncomplicated malaria in Kenya and other countries in the region.
Akhwale Willis S   +3 more
doaj   +1 more source

MOESM2 of Efficacy of artemetherâ lumefantrine, artesunateâ amodiaquine, and dihydroartemisininâ piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015

open access: yes, 2017
Additional file 2. Lengths of neutral microsatellite markers for late treatment failures and randomly chosen treatment successes, Angola therapeutic efficacy monitoring, 2015.
Plucinski, Mateusz   +17 more
openaire   +1 more source

Home - About - Disclaimer - Privacy